The CME Institute | Psychiatrist.com

Innovative and accredited continuing medical education for today’s practicing clinicians.

CME Institute is trusted by physicians across medical specialties for premium continuing education that yields the highest educational outcomes. These ACCME-accredited activities make the latest research, novel therapies, and clinical best practices accessible and approachable for physician, NP, PA, and PharmD learners.

Expert-led insights to improve patient outcomes
Multi-modal courses to suit all learning styles
Timely topics for relevant application to practice
Razor-focused approach to innovation that includes documentary-style video and micro-learning Tweetorials
A commitment to collective mindfulness

Recent courses

Video Self-study / Enduring Comparing LAI and Oral Antipsychotic Options: Expert Discussions with Schizophrenia Case Reports Schizophrenia/ Schizoaffective Disorders LAI antipsychotics are often initiated late in adults with schizophrenia, despite evidence supporting early use. Experts discuss the barriers to initiating LAI treatment, as well as adherence, efficacy and safety data. 1.00 AMA PRA Category 1 Credit™ 1.00 Participation	Journal Self-study / Enduring Diagnosing and Treating Alzheimer Disease During the Early Stage Alzheimer Disease Many new therapies for early-stage AD have made their way onto the scene that can delay onset of the disease and/or slow down progression. Find out the how, what, when to better treat your patients with AD from specialists in the field. 1.00 AMA PRA Category 1 Credit™ 1.00 Participation	Journal Self-study / Enduring Patient-Specific Considerations, the GABA Pathway, and New Clinical Trial Data on Neuroactive Steroids in MDD and PPD Depression Major Depressive Disorder Women’s Mental Health Studies evaluating neuroactive steroid GABA-A receptor positive allosteric modulators demonstrate promising results for the treatment of MDD and PPD. 1.50 AMA PRA Category 1 Credit™ 1.50 Participation
Video Self-study / Enduring Seizure Clusters in the Real World: The Call to Arms Epilepsy Treatment standards for neurologists and other clinicians caring for patients with epilepsy with emphasis on understanding epilepsy epidemiology, SUDEP and ILAE Classification updates, and therapeutic strategies. 0.50 AMA PRA Category 1 Credit™ 0.50 Participation	Video Self-study / Enduring Therapeutic Advances for Epileptic Seizure Rescue Epilepsy Neurologists and other clinicians can improve care by identifying individuals who are susceptible to seizure clusters and educating them on rescue therapies and medications. 0.50 AMA PRA Category 1 Credit™ 0.50 Participation	Tweetorial Self-study / Enduring Tweetorial: CKD in Real-World Practice: Examine a Patient Case Renal Disease Cardiology Experts examine a patient case study as a way of translating guideline-based screening recommendations and current therapies that protect T2D patients from CKD progression in real-world practice. 0.25 AMA PRA Category 1 Credit™ 0.25 Participation
Video Self-study / Enduring Parkinson's Disease Psychosis: Review of Neuropsychiatric Complications Parkinson Disease An average of 35% of patients diagnosed with Parkinson’s disease experience Parkinson’s psychosis. Recognition and diagnosis of this nonmotor manifestation is critical in choosing the best treatment strategy and managing these symptoms. 0.50 AMA PRA Category 1 Credit™ 0.50 Participation	Tweetorial Self-study / Enduring Tweetorial: A Rationale for Treating CKD with Combination Therapy Renal Disease Cardiology Clinicians have a number of therapeutic agents to choose from when treating T2D at risk of CKD. However, it's important to know how to sequence these therapies in real-world practice. 0.25 AMA PRA Category 1 Credit™ 0.25 Participation	Video Self-study / Enduring Episode 1: Why the Duration Until Onset of Antidepressant Matters Depression Major Depressive Disorder Women’s Mental Health Pharmacology for MDD is limited by low efficacy, delayed response, and side effects. Research on the pathophysiology of the disease that includes the glutamatergic system and GABA signaling is ushering in a new era for rapidly acting antidepressants. 0.50 AMA PRA Category 1 Credit™ 0.50 Participation
Video Self-study / Enduring Episode 2: Update on Rapid-Onset Therapies for Major Depressive Disorder Depression Major Depressive Disorder Women’s Mental Health The new fast-acting antidepressants esketamine, an NMDA receptor antagonist, and positive allosteric modulators of GABAergic neurotransmission brexanolone and zuranolone have created an important and exciting paradigm shift in the treatment of depression. 0.50 AMA PRA Category 1 Credit™ 0.50 Participation	Tweetorial Self-study / Enduring Tweetorial: Improving Clinician Awareness of #RettSyndrome and Optimizing Management of Care Across the Patient Lifespan Rett Syndrome Because of the multiple comorbidities and symptoms associated with Rett syndrome, clinicians are advised to implement a multidisciplinary approach to disease management with an eye toward new and emerging therapies on the horizon. 0.25 AMA PRA Category 1 Credit™ 0.25 Participation	Video Self-study / Enduring Improving Clinician Awareness of Rett Syndrome and Optimizing Management of Care Across the Patient Lifespan Rett Syndrome Child and Adolescent Psychiatry Movement Disorders Neurology Because of the multiple comorbidities associated with Rett syndrome, clinicians are advised to incorporate clinical guidelines that suggest implementing therapeutics with a multidisciplinary approach and with an eye toward new and emerging therapies. 1.00 AMA PRA Category 1 Credit™ 1.00 Participation

Pages

My Courses

Please login or create an account to view your activities.

Transcript

Please login or create an account to view your activities.